Evidence map›Paper›PMID 31583938›Full record

SynthesisJournal of the American Heart Association2019

Clinical Prediction Models for Valvular Heart Disease.

Benjamin S Wessler, Christine M Lundquist, Benjamin Koethe, Jinny G Park, Kristen Brown, Tatum Williamson, Muhammad Ajlan, Zuhair Natto, Jennifer S Lutz, Jessica K Paulus and 1 more

Abstract readSystematic Review
In one paragraph

Synthesis in Journal of the American Heart Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Clinical Prediction Models for Valvular Heart Disease.Journal of the American Heart Association · 2019
    Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Benjamin S WesslerPredictive Analytics and Comparative Effectiveness (PACE) Center Institute for Clinical Research and Health Policy Studies (ICRHPS) Tufts Medical Center Boston MA.
Christine M LundquistPredictive Analytics and Comparative Effectiveness (PACE) Center Institute for Clinical Research and Health Policy Studies (ICRHPS) Tufts Medical Center Boston MA.
Benjamin KoethePredictive Analytics and Comparative Effectiveness (PACE) Center Institute for Clinical Research and Health Policy Studies (ICRHPS) Tufts Medical Center Boston MA.
Jinny G ParkPredictive Analytics and Comparative Effectiveness (PACE) Center Institute for Clinical Research and Health Policy Studies (ICRHPS) Tufts Medical Center Boston MA.
Kristen BrownPredictive Analytics and Comparative Effectiveness (PACE) Center Institute for Clinical Research and Health Policy Studies (ICRHPS) Tufts Medical Center Boston MA.
Tatum WilliamsonPredictive Analytics and Comparative Effectiveness (PACE) Center Institute for Clinical Research and Health Policy Studies (ICRHPS) Tufts Medical Center Boston MA.
Muhammad AjlanPredictive Analytics and Comparative Effectiveness (PACE) Center Institute for Clinical Research and Health Policy Studies (ICRHPS) Tufts Medical Center Boston MA.
Zuhair NattoDepartment of Dental Public Health Faculty of Dentistry King Abdulaziz University Jeddah Saudi Arabia.
Jennifer S LutzPredictive Analytics and Comparative Effectiveness (PACE) Center Institute for Clinical Research and Health Policy Studies (ICRHPS) Tufts Medical Center Boston MA.
Jessica K PaulusPredictive Analytics and Comparative Effectiveness (PACE) Center Institute for Clinical Research and Health Policy Studies (ICRHPS) Tufts Medical Center Boston MA.
David M KentPredictive Analytics and Comparative Effectiveness (PACE) Center Institute for Clinical Research and Health Policy Studies (ICRHPS) Tufts Medical Center Boston MA.

Funding

Tufts Clinical and Translational Science Institute (Pilot Supplement)UL1TR002544 · NCATS · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2018 to 2022
$50.2M
Palliative Care for High-Risk TAVR Patients: The Impact of MultimorbidityK23AG055667 · NIA · TUFTS MEDICAL CENTER · PI WESSLER, BENJAMIN SETH · 2018 to 2022
$948k
Improving Care for Patients with Aortic Stenosis and MultimorbidityR03AG056447 · NIA · TUFTS MEDICAL CENTER · PI WESSLER, BENJAMIN SETH · 2017 to 2018
$263k
NCATS NIH HHS UL1 TR002544NIA NIH HHS K23 AG055667NIA NIH HHS R03 AG056447
6 · The paper itself

Abstract

Background While many clinical prediction models (CPMs) exist to guide valvular heart disease treatment decisions, the relative performance of these CPMs is largely unknown. We systematically describe the CPMs available for patients with valvular heart disease with specific attention to performance in external validations. Methods and Results A systematic review identified 49 CPMs for patients with valvular heart disease treated with surgery (n=34), percutaneous interventions (n=12), or no intervention (n=3). There were 204 external validations of these CPMs. Only 35 (71%) CPMs have been externally validated. Sixty-five percent (n=133) of the external validations were performed on distantly related populations. There was substantial heterogeneity in model performance and a median percentage change in discrimination of -27.1% (interquartile range, -49.4%--5.7%). Nearly two-thirds of validations (n=129) demonstrate at least a 10% relative decline in discrimination. Discriminatory performance of EuroSCORE II and Society of Thoracic Surgeons (2009) models (accounting for 73% of external validations) varied widely: EuroSCORE II validation c-statistic range 0.50 to 0.95; Society of Thoracic Surgeons (2009) Models validation c-statistic range 0.50 to 0.86. These models performed well when tested on related populations (median related validation c-statistics: EuroSCORE II, 0.82 [0.76, 0.85]; Society of Thoracic Surgeons [2009], 0.72 [0.67, 0.79]). There remain few (n=9) external validations of transcatheter aortic valve replacement CPMs. Conclusions Many CPMs for patients with valvular heart disease have never been externally validated and isolated external validations appear insufficient to assess the trustworthiness of predictions. For surgical valve interventions, there are existing predictive models that perform reasonably well on related populations. For transcatheter aortic valve replacement (CPMs additional external validations are needed to broadly understand the trustworthiness of predictions.

Indexed as

Decision Support TechniquesGlobal HealthHeart Valve DiseasesHeart Valve Prosthesis ImplantationHospital MortalityHumansPrognosisRisk AssessmentRisk FactorsSurvival Rateclinical prediction modelsriskvalvular heart disease

Identifiers

PMID31583938
PMCPMC6818049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.